Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials, say ...

PATIENTS AND METHODS: We surveyed 1,081 women (response, 70%) diagnosed with early-stage breast cancer in Massachusetts or Minnesota about their desired and actual roles in treatment decision making ...

While Carter continues to visit UAB for regular checkups, she has now been cancer-free for over three years. She uses her ...

A blood test can help identify rare mutations in advanced breast cancer, which may enable patients to access effective treatment more quickly in the future, Cancer Research UK-funded scientists have ...

Less than 5% of patients with cancer enroll in clinical trials, and 1 in 5 trials are stopped for poor accrual. We evaluated an automated clinical trial matching system that uses natural language ...

ANN ARBOR, Mich. — As cancer researchers continue to identify genetic mutations driving different cancer subtypes, they are also creating a catalog of possible targets for new treatments. The ...

For women undergoing implant-based reconstruction and for patients undergoing bone grafting procedures, atopic diseases are ...

This ambitious program leverages Massive Bio’s AI capabilities and Trial Command Center to significantly accelerate oncology clinical research and bring clinical trial access to the masses NEW ...

Each year millions of people are diagnosed with cancer. Meanwhile, hundreds of clinical trials testing potential treatments are ongoing. But there’s a gap between the people who need treatment and the ...